MTP activity inhibition decreases HCV envelope glycoprotein secretion by E1E2-HepG2 and E1E2-Huh-7.5. by Vinca Icard (374872)

Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation - Fig 5 by Femke van Diggelen (6499112)

A ratio showing a decrease in the volume of the biggest cavity during the last stage of the simulations (elongation). by Łukasz Mioduszewski (8967434)

Changes in neuronal morphology after 150 nM sAPP-Fc added to 5DIV neurons. by Stéphanie Chasseigneaux (231744)

“…<p>Morphometric analysis 96 hours after the addition of 150 nM sAPP-Fc to 5DIV neurons shows that: (<b>A</b>) sAPP-Fc induces a significant decrease of primary dendrite number (control (Ctrl) vs sAPP-Fc: p<0.0276). …”

Stable overexpression of PFKFB3-5 in HEK-293 and U87 cells leads to decreased cell viability and proliferation while leaving transcriptional profile of PFKFB3-1 and -11 unaltered. by Ulli Heydasch (11091062)

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

A blue-shifted fluorescence donor increases fAP amplitude but exhibits a decreased SNR. A. by Ann E. Fink (312543)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Effects of ghrelin (5 nM) on membrane potential (MP in mV) and input resistance (IR in MΩ) of NPY GFP neurons in VMH slices. by Hiroshi Hashiguchi (2451034)

Acetylcholine-induced NO- and EDHF-mediated relaxations decrease with increasing age. by Noureddine Idris Khodja (331400)

NETs decrease <i>T</i>. <i>cruzi</i> infectivity. by Daniel Sousa-Rocha (802734)

Decrease of actin velocity when passing confined TCR clusters. by Cheng-han Yu (244912)

Oxytocin decreases cycle amplitude of FL without changing periodicity. by Francesco Dose (540963)

Treatment with IVIg is associated with a transient decrease in levels of PFR-MCA hydrolyzing IgG. by Ankit Mahendra (446529)

Filter-extruded niosomes decrease in size upon freezing and thawing. by Rianne Bartelds (1343631)

“…Prior to the analysis the vesicles were extruded 15 times through a 200 nm polycarbonate filter. B-C: Cryo-EM pictures of niosomes composed of unsaturated surfactants plus cholesterol without (B) and with five freeze and thaw cycles (C). …”

STX decreases the K_ATP channel activity. by Ana B. Ropero (12180)

Exogenous FGF4 decreases osteogenic differentiation of mESCs. by Sung-Ho Kook (445098)

HDAC inhibition by TSA decreases SREBP2 proteolytic cleavage. by Maria João Nunes (160499)

Su(H) and RBPJ AOS variants decrease DNA binding. by Ellen K. Gagliani (11478756)

Vasopressin decreases EPSPs in CA2 after LTP induction. by Magda Chafai (295116)

“…Vasopressin (AVP 10 nM; 1 min) applied during LTP transiently decreased the EPSP amplitude. …”